Business
Press Release Nov 11 2020
Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 11, 2020, titled "Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg".
About this update from Glenmark Pharmaceuticals Limited
[{"type":"text","content":" Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 11, 2020, titled \"Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg\". View Attachment","length":370,"tagName":"div"}]